Cargando…

Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”

Detalles Bibliográficos
Autores principales: Zhang, Qing, Zhang, Haixu, Ding, Jiage, Liu, Hongyan, Li, Huizhong, Li, Hailong, Lu, Mengmeng, Miao, Yangna, Li, Liantao, Zheng, Junnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458869/
https://www.ncbi.nlm.nih.gov/pubmed/31032372
http://dx.doi.org/10.1155/2019/2070562
_version_ 1783410102107111424
author Zhang, Qing
Zhang, Haixu
Ding, Jiage
Liu, Hongyan
Li, Huizhong
Li, Hailong
Lu, Mengmeng
Miao, Yangna
Li, Liantao
Zheng, Junnian
author_facet Zhang, Qing
Zhang, Haixu
Ding, Jiage
Liu, Hongyan
Li, Huizhong
Li, Hailong
Lu, Mengmeng
Miao, Yangna
Li, Liantao
Zheng, Junnian
author_sort Zhang, Qing
collection PubMed
description
format Online
Article
Text
id pubmed-6458869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64588692019-04-28 Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models” Zhang, Qing Zhang, Haixu Ding, Jiage Liu, Hongyan Li, Huizhong Li, Hailong Lu, Mengmeng Miao, Yangna Li, Liantao Zheng, Junnian J Immunol Res Corrigendum Hindawi 2019-03-27 /pmc/articles/PMC6458869/ /pubmed/31032372 http://dx.doi.org/10.1155/2019/2070562 Text en Copyright © 2019 Qing Zhang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Zhang, Qing
Zhang, Haixu
Ding, Jiage
Liu, Hongyan
Li, Huizhong
Li, Hailong
Lu, Mengmeng
Miao, Yangna
Li, Liantao
Zheng, Junnian
Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title_full Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title_fullStr Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title_full_unstemmed Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title_short Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
title_sort corrigendum to “combination therapy with epcam-car-nk-92 cells and regorafenib against human colorectal cancer models”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458869/
https://www.ncbi.nlm.nih.gov/pubmed/31032372
http://dx.doi.org/10.1155/2019/2070562
work_keys_str_mv AT zhangqing corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT zhanghaixu corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT dingjiage corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT liuhongyan corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT lihuizhong corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT lihailong corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT lumengmeng corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT miaoyangna corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT liliantao corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels
AT zhengjunnian corrigendumtocombinationtherapywithepcamcarnk92cellsandregorafenibagainsthumancolorectalcancermodels